• CD38 CAR Binder Structure and Affinity Tuning

  2026-08-17

  Cheng et al. structurally distinguish two CD38-targeting CAR binders, RP02 and 028, showing that epitope geometry can control enzymatic inhibition as well as receptor affinity. The study supports rationally attenuated CAR design as a way to reduce fratricide while preserving antitumor cytotoxicity, and it provides a framework for interpreting cell-death measurements in engineered T-cell studies.

• Luminescent ATP Detection Assay Kit for GBM

  2026-08-16

  Learn how the Luminescent ATP Detection Assay Kit can translate PXDN–LDHA glycolytic biology into a robust ATP endpoint for glioblastoma research. This guide focuses on assay interpretation, matrix-aware workflow design, normalization, and the limits of using ATP as a surrogate for metabolic flux.

• Phalloidin B7678: Fixed-Cell F-Actin Workflow

  2026-08-15

  Phalloidin (SKU B7678) is a high-affinity F-actin-binding cyclic heptapeptide toxin for stabilizing filament architecture in fixed, permeabilized cells, tissue sections, and cell-free assays. This guide covers dossier-listed parameters and QC practices; it should not be used for live-cell imaging or experiments requiring reversible cytoskeletal dynamics.

• Irinotecan and the Gut–Liver Axis in Steatohepatitis

  2026-08-14

  The reference study identifies intestinal barrier failure, lipopolysaccharide translocation, and excessive neutrophil extracellular trap formation as a mechanistic chain linking CPT-11 exposure to chemotherapy-induced steatohepatitis. Its findings position fucoidan-mediated barrier preservation and NETs suppression as investigational strategies for reducing irinotecan-associated liver injury without treating hepatotoxicity as an isolated hepatic event.

• Dual PI3K–AKT–ERK Blockade in Gefitinib Resistance

  2026-08-14

  Deng and colleagues developed a rational dual-drug nanoplatform to address gefitinib resistance and metastatic behavior in lung adenocarcinoma. By combining pathway analysis, synergy testing, phospho-proteomics, cellular models, xenografts, and zebrafish experiments, the study links coordinated PI3K–AKT and ERK inhibition with improved antitumor activity.

• Live-Dead Bacterial Staining Kit for Nanomaterials

  2026-08-13

  The Live-Dead Bacterial Staining Kit enables membrane-based bacterial viability assessment with NucGreen dye and EthD-III. This guide explains how to interpret dual fluorescence when testing pH-responsive and magnetic antibacterial nanomaterials.

• Luminescent ATP Detection Assay Kit Workflow

  2026-08-13

  Learn how to apply a firefly luciferase ATP assay to hepatocyte infection models, mitochondrial injury studies, and tissue bioenergetics. This workflow combines rapid lysis, broad-range calibration, and ATP normalization with apoptosis and oxidative-stress readouts.

• WNT5a/GSK3/β-Catenin Control of FAP Adipogenesis

  2026-08-12

  The reference study identifies the WNT5a/GSK3/β-catenin axis as a key regulator of adipogenic drift in skeletal muscle fibro/adipogenic progenitors. By combining pharmacological, cytometric, transcriptomic, and computational approaches, it shows that GSK3 inhibition suppresses FAP adipogenesis, limits muscle fat accumulation, and improves the pro-myogenic activity of the muscle niche.

• Nile Red (B8209) for Lipid Droplet Imaging

  2026-08-12

  Nile Red, also known as Nile blue oxazone, is a lipophilic fluorescent dye for intracellular lipid droplet staining and lipid distribution imaging. Its wavelength-dependent fluorescence can distinguish lipid droplets from membrane-associated signal, but fluorescence intensity alone does not establish lipid metabolism or autophagic flux.

• Apis mellifera Smo and Olfactory Signaling

  2026-08-11

  The 2024 study by Guo and colleagues identifies and functionally analyzes Smoothened in Apis mellifera, linking antenna-enriched Smo expression with olfactory receptor transcription, electroantennographic responses, and odor-directed behavior. Its pharmacological gain- and loss-of-function design provides a useful framework for studying Hedgehog signaling in insect sensory biology while highlighting important limits on extrapolation to mammalian systems.

• KCNE4-Dependent Modulation of Kv1.3 Pharmacology

  2026-08-11

  The reference study shows that the auxiliary subunit KCNE4 changes how Kv1.3 responds to blockers without substantially changing blocker affinity. By comparing the extracellular pore blocker margatoxin with the intracellular compound Psora 4, the authors identify a stoichiometry-dependent effect on inhibition kinetics that links channel architecture to pharmacological interpretation in leukocytes.

• 3-Hydroxybutyrate: A Translational Neuroprotection Signal

  2026-08-10

  3-hydroxybutyrate (BHBA) is more than a ketone fuel: it is a metabolic, membrane, ferroptosis, and chromatin-regulatory research tool. This article connects stroke neuroprotection findings with practical BHBA assay design, product selection, translational strategy, and the limits of extending ketone-body biology across experimental domains.

• Autophagy–Liver Metastasis Signature in Colorectal Cancer

  2026-08-09

  Bai et al. integrate autophagy and liver-metastasis biology with bulk and single-cell transcriptomics to develop a six-gene prognostic signature for colorectal cancer. The model stratifies survival risk and links high-risk disease with macrophage polarization, CD8+ T-cell exhaustion, potential immunotherapy resistance, and altered therapeutic sensitivity.

• BHBA and the Next Frontier of Neuroprotection

  2026-08-08

  3-hydroxybutyrate (BHBA) is emerging as more than a fuel substitute: it is a controllable metabolic signal that may connect ketone biology, ferroptosis resistance, membrane function, and chromatin regulation. This article interprets recent stroke findings and provides a practical framework for using BHBA in translational research.

• Vincristine Sulfate: From Microtubules to Translation

  2026-08-07

  A translational framework for using vincristine sulfate in cancer research, connecting tubulin polymerization, microtubule dynamics, quantitative assay design, and in vivo interpretation while defining the limits of cross-domain evidence.

8447 records 4/564 page Previous Next 12345 下5页 Last page